NANOBIOTIX

nanobiotix-logo

Nanobiotix SA develops nanomedicine programs for the treatment of cancer. The company provides NanoXray that offers a solution for cancer therapy based on a technology that is designed to allow destruction of cancer cells by inert particles. Its products include magnetic particles and laser activated nanoparticles for the treatment and diagnostic of cancer.

#People #Financial #Website #More

NANOBIOTIX

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2003-01-01

Address:
Paris, Ile-de-France, France

Country:
France

Website Url:
http://www.nanobiotix.com

Total Employee:
101+

Status:
Active

Contact:
+33140260755

Email Addresses:
[email protected]

Total Funding:
323.51 M USD

Technology used in webpage:
IPv6 Google Maps Person Schema WordPress 6.0 Gravatar Profiles Apple Whitelist Reddit Akamai Hosted WP Fastest Cache EU Cookie Law


Current Employees Featured

elsa-borghi_image

Elsa Borghi
Elsa Borghi Chief Medical Officer @ Nanobiotix
Chief Medical Officer
2008-03-01

laurent-levy_image

Laurent Levy
Laurent Levy Co-Founder, Persident & CEO @ Nanobiotix
Co-Founder, Persident & CEO
2003-04-01

not_available_image

Kader Boussaha
Kader Boussaha CFO & COO @ Nanobiotix
CFO & COO

bart-van-rhijn_image

Bart Van Rhijn
Bart Van Rhijn Chief Financial Officer @ Nanobiotix
Chief Financial Officer
2021-06-01

mikaela-dimitriu_image

Mikaela Dimitriu
Mikaela Dimitriu Vice President Global Head Medical Affairs @ Nanobiotix
Vice President Global Head Medical Affairs
2017-01-01

Founder


laurent-levy_image

Laurent Levy

Stock Details


Company's stock symbol is NASDAQ:NBTX

Investors List

european-investment-bank_image

European Investment Bank

European Investment Bank investment in Post-IPO Debt - Nanobiotix

european-investment-bank_image

European Investment Bank

European Investment Bank investment in Post-IPO Debt - Nanobiotix

bpifrance_image

Bpifrance

Bpifrance investment in Grant - Nanobiotix

bpifrance_image

Bpifrance

Bpifrance investment in Series E - Nanobiotix

amorage-rhne-alpes_image

Amorçage Rhône Alpes

Amorçage Rhône Alpes investment in Series C - Nanobiotix

cm-cic-capital-innovation_image

Crédit Mutuel Innovation

Crédit Mutuel Innovation investment in Series C - Nanobiotix

matignontechnologies_image

Matignon Technologies

Matignon Technologies investment in Series C - Nanobiotix

karista_image

Karista

Karista investment in Series C - Nanobiotix

seventure-partners_image

Seventure Partners

Seventure Partners investment in Series C - Nanobiotix

otc-asset-management_image

Apicap

Apicap investment in Series C - Nanobiotix

Official Site Inspections

http://www.nanobiotix.com Semrush global rank: 2.68 M Semrush visits lastest month: 6.23 K

  • Host name: nanobiotix.tempurl.host
  • IP address: 95.179.157.236
  • Location: Amsterdam Netherlands
  • Latitude: 52.3534
  • Longitude: 4.9087
  • Timezone: Europe/Amsterdam
  • Postal: 1091

Loading ...

More informations about "Nanobiotix"

Nanomedicine pioneers - The story behind Nanobiotix | Nanobiotix

Learn how Nanobiotix uses physics to expand therapeutic possibilities for patients. LATEST NEWS. NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial …See details»

Nanobiotix - Wikipedia

Nanobiotix is a spin-off of the State University of New York at Buffalo that was incorporated in 2003 [3] and has been primarily funded by leading European venture capital firms (Matignon …See details»

Nanobiotix - LinkedIn

Nanobiotix | 17,575 followers on LinkedIn. Building new therapies atom by atom. | Incorporated in 2003, Nanobiotix is a leading, late clinical-stage nanotherapeutics company pioneering new ...See details»

Nanobiotix - Crunchbase Company Profile & Funding

Nanobiotix SA develops nanomedicine programs for the treatment of cancer. The company provides NanoXray that offers a solution for cancer therapy based …See details»

Investor Relations – Nanobiotix

Nanobiotix is a clinical-stage biotechnology company focused on developing first-in-class product candidates that use proprietary nanotechnology to transform cancer treatment. NBTXR3 – …See details»

Nanobiotix Corp. Company Profile | Cambridge, MA | Competitors ...

Find company research, competitor information, contact details & financial data for Nanobiotix Corp. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»

Nanobiotix - The Org

Nanobiotix is a biotechnology company that uses nanomedicine to develop new radiotherapy techniques for cancer patients.See details»

Nanobiotix - Leadership Team - The Org

The Leadership Team at Nanobiotix is responsible for guiding the strategic direction of the company and ensuring the successful development and implementation of innovative …See details»

Nanobiotix (EPA:NANO) Company Profile & Description - Stock …

Apr 4, 2025 Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product …See details»

Nanobiotix Org Chart + Executive Team - The Official Board

The organizational chart of Nanobiotix displays its 16 main executives including Laurent Levy, Bart Van Rhijn and Patrick Tricoli. Toggle navigation The Official Board. Search. Search. …See details»

Nanobiotix - Simple English Wikipedia, the free encyclopedia

Nanobiotix is a biotechnology company. It uses nanomedicine to develop new radiotherapy techniques for cancer patients. The home office of the company is in Paris. Also, it has offices …See details»

NANOBIOTIX Announces License Agreement for Worldwide Co …

Jul 10, 2023 The price of the initial tranche will be equal to $5.21 per American Depositary Share (“ADS”) if that price (1) is approved by Nanobiotix shareholders or (2) exceeds 85% of the …See details»

Nanobiotix - MassBio

May 29, 2020 Incorporated in 2003, Nanobiotix is a leading, clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing …See details»

Nanobiotix Company Profile - Craft

Oct 29, 2024 Nanobiotix has 5 employees across 2 locations and €30.06 m in annual revenue in FY 2023. See insights on Nanobiotix including office locations, competitors, revenue, …See details»

Nanobiotix Announces Full Results From Completed Phase 1 Study ...

1 day ago Nanobiotix : Communications Department Brandon Owens VP, Communications +1 (617) 852-4835 [email protected]: Investor Relations Department Ricky Bhajun …See details»

Nanobiotix - Overview, News & Similar companies | ZoomInfo.com

Who is Nanobiotix. Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment ou tcomes for …See details»

Nanobiotix - Contacts, Employees, Board Members, Advisors

Nanobiotix is a nanomedicine company developing novel therapeutics for the local treatment of cancer. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. …See details»

Nanobiotix Announces Presentation of Full Results From …

6 days ago Further information on the risk factors that may affect company business and financial performance is included in Nanobiotix’s Annual Report on Form 20-F filed with the …See details»

Nanobiotix | Nanotechnology Company | NPD

Incorporated in 2003, Nanobiotix is a leading, late clinical-stage nanomedicine company pioneering new approaches to significantly change patient outcomes by bringing nanophysics …See details»

Nanobiotix - Press release - October 20, 2021 - American Society …

Cambridge, Massachusetts (United States), France, Spain, and Germany. Nanobiotix has been listed on the regulated market of Euronext in Paris since 2012 and on the Nasdaq Global …See details»

linkstock.net © 2022. All rights reserved